Anuh Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE489G01022
  • NSEID: ANUHPHR
  • BSEID: 506260
INR
82.25
2.96 (3.73%)
BSENSE

Dec 05

BSE+NSE Vol: 1.77 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Anuh Pharma Ltd stock-summary
stock-summary
Anuh Pharma Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Anuh Pharma Limited is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs). The Company is engaged in the business of manufacturing and selling of "Bulk drugs and chemicals. The company is part of the SK Group with the key products including antibiotics, erythromycin salts, chloramphenicol and other chemicals. It is well positioned to service its existing and potential markets through its manufacturing operations at Tarapur in Maharashtra.
Company Coordinates stock-summary
Company Details
3-A Shivsagar Estate, North Wing Dr A B Road Worli Mumbai Maharashtra : 400018
stock-summary
Tel: 91-22-6622 7575
stock-summary
anuh@sk1932.com
Registrar Details
Bigshare Services Pvt Ltd , E-2 , Ansa Industrial Estate, Saki Vihar Road, Saki Naka, Andheri (E), Mumbai
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 50.11 Cr
Number of Shares
10.02 Cr
Face Value
INR 5.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
15-Jul-2025
10.02
50.11
50112000
5
Bonus Issue
18-Sep-2020
5.01
25.06
25056000
5
Bonus Issue
05-Aug-2015
2.51
12.53
16704000
5
Bonus
05-Aug-2015
2.51
12.53
16704000
5
Bonus
28-Oct-2010
83.52
4.18
5568000
5
Bonus
28-Oct-2010
83.52
4.18
5568000
5
Bonus
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 2 Schemes (0.0%)

FIIs

Held by 1 FIIs (0.0%)

Promoter with highest holding

Bharti Bipin Shah (19.43%)

Highest Public shareholder

None

Individual Investors Holdings

23.86%

stock-summary Board of Directorsstock-summary
stock-summary
Management
Designation
Remuneration
Bipin N Shah
Vice Chairman
3.65 lacs
Bharat N Shah
Non-Exec & Non-Independent Dir
2.4 lacs
Arun L Todarwal
Non-Exec. & Independent Dir.
4.9 lacs
Samir J Shah
Non-Exec & Non-Independent Dir
35.0 k
Ketan L Shah
Non-Exec & Non-Independent Dir
1.4 lacs
Ritesh B Shah
Joint Managing Director
63.1 lacs
Vivek B Shah
Joint Managing Director
62.3 lacs
Jasvantlal Shah
Chairman & Independent Directo
4.9 lacs
Mita Dixit
Non-Exec & Non-Independent Dir
1.75 lacs
Harmanbhai Tulsibhai Patel
Non-Exec. & Independent Dir.
3.15 lacs
Sandeep M Joshi
Non-Exec. & Independent Dir.
1.4 lacs
Hemant Auti
Company Sec. & Compli. Officer
0
Pradeep Thakur
Independent Director
0
Siddharth Shah
Independent Director
0
Gaurav Shah
Independent Director
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
Bulk Drugs & Chemicals
460.158
0%
 
100
Bulk Drugs & Chemicals
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Pharmaceuticals, Medicinal Chemical and Botanical Products
316.13
98.11%
Other Operating Income
4.54
1.41%
 
98.11
Pharmaceuticals, Medicinal Chemical and Botanical Products
1.89
Pharmaceuticals, Medicinal Chemical and Botanical Products
1.41
Other Operating Income
98.59
Other Operating Income
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
186 Cr
(Quarterly Results - Sep 2025)
Net Profit:
8 Cr
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 797 Cr (Micro Cap)

stock-summary
P/E

21.00

stock-summary
Industry P/E

34

stock-summary
Dividend Yield

1.89%

stock-summary
Debt Equity

-0.04

stock-summary
Return on Equity

11.84%

stock-summary
Price to Book

2.43